|
1
|
Prasad SR, Humphrey PA, Catena JR, Narra
VR, Srigley JR, Cortez AD, Dalrymple NC and Chintapalli KN: Common
and uncommon histologic subtypes of renal cell carcinoma: Imaging
spectrum with pathologic correlation. Radiographics. 26:1795–1806;
discussion 1806–1810. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rini BI and Atkins MB: Resistance to
targeted therapy in renal-cell carcinoma. Lancet Oncol.
10:992–1000. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Linehan WM, Srinivasan R and Schmidt LS:
The genetic basis of kidney cancer: A metabolic disease. Nat Rev
Urol. 7:277–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kahn BB, Alquier T, Carling D and Hardie
DG: AMP-activated protein kinase: Ancient energy gauge provides
clues to modern understanding of metabolism. Cell Metab. 1:15–25.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luo Z, Saha AK, Xiang X and Ruderman NB:
AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci.
26:69–76. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hoyer-Hansen M and Jäättelä M:
AMP-activated protein kinase: a universal regulator of autophagy?
Autophagy. 3:381–383. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Imamura K, Ogura T, Kishimoto A, Kaminishi
M and Esumi H: Cell cycle regulation via p53 phosphorylation by a
5′-AMP activated protein kinase activator, 5-aminoimidazole-
4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular
carcinoma cell line. Biochem Biophys Res Commun. 287:562–567. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cho SY, Lee HJ, Lee HJ, Jung DB, Kim H,
Sohn EJ, Kim B, Jung JH, Kwon BM and Kim SH: Activation of
amp-activated protein kinase α and extracelluar signal-regulated
kinase mediates CB-PIC-induced apoptosis in hypoxic sw620
colorectal cancer cells. Evid Based Complement Alternat Med.
2013:9743132013. View Article : Google Scholar
|
|
10
|
Kim CJ, Cho YG, Park JY, Kim TY, Lee JH,
Kim HS, Lee JW, Song YH, Nam SW, Lee SH, et al: Genetic analysis of
the LKB1/STK11 gene in hepatocellular carcinomas. Eur J Cancer.
40:136–141. 2004. View Article : Google Scholar
|
|
11
|
Lee CW, Wong LL, Tse EY, Liu HF, Leong VY,
Lee JM, Hardie DG, Ng IO and Ching YP: AMPK promotes p53
acetylation via phosphorylation and inactivation of SIRT1 in liver
cancer cells. Cancer Res. 72:4394–4404. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Denizot F and Lang R: Rapid colorimetric
assay for cell growth and survival. Modifications to the
tetrazolium dye procedure giving improved sensitivity and
reliability. J Immunol Methods. 89:271–277. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen HM, Lin JTK CY and Huang CF: The
Effects of Novel AMPK Activator on Human Vascular Endothelial
Cells. J Med Bioeng. 3:52014.
|
|
14
|
Youn SH, Lee JS, Lee MS, Cha EY, Thuong
PT, Kim JR and Chang ES: Anticancer properties of pomolic
acid-induced AMP-activated protein kinase activation in MCF7 human
breast cancer cells. Biol Pharm Bull. 35:105–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karnevi E, Said K, Andersson R and
Rosendahl AH: Metformin-mediated growth inhibition involves
suppression of the IGF-I receptor signalling pathway in human
pancreatic cancer cells. BMC Cancer. 13:2352013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng QY, Jin FS, Yao C, Zhang T, Zhang GH
and Ai X: Ursolic acid-induced AMP-activated protein kinase (AMPK)
activation contributes to growth inhibition and apoptosis in human
bladder cancer T24 cells. Biochem Biophys Res Commun. 419:741–747.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sauer H, Engel S, Milosevic N, Sharifpanah
F and Wartenberg M: Activation of AMP-kinase by AICAR induces
apoptosis of DU-145 prostate cancer cells through generation of
reactive oxygen species and activation of c-Jun N-terminal kinase.
Int J Oncol. 40:501–508. 2012.
|
|
18
|
Hadad SM, Hardie DG, Appleyard V and
Thompson AM: Effects of metformin on breast cancer cell
proliferation, the AMPK pathway and the cell cycle. Clin Transl
Oncol. 16:746–752. 2014. View Article : Google Scholar
|
|
19
|
Hickman JA: Apoptosis induced by
anticancer drugs. Cancer Metastasis Rev. 11:121–139. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wolf BB and Green DR: Suicidal tendencies:
apoptotic cell death by caspase family proteinases. J Biol Chem.
274:20049–20052. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Slee EA, Harte MT, Kluck RM, Wolf BB,
Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri
ES, et al: Ordering the cytochrome c-initiated caspase cascade:
Hierarchical activation of caspases-2, -3, -6, -7, -8 and -10 in a
caspase-9-dependent manner. J Cell Biol. 144:281–292. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thornberry NA: Caspases: Key mediators of
apoptosis. Chem Biol. 5:R97–103. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Charalambous C, Pitta CA and Constantinou
AI: Equol enhances tamoxifen's anti-tumor activity by induction of
caspase-mediated apoptosis in MCF-7 breast cancer cells. BMC
Cancer. 13:2382013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jones RG, Plas DR, Kubek S, et al:
AMP-activated protein kinase induces a p53-dependent metabolic
checkpoint. Mol Cell. 18:283–293. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vazquez-Martin A, López-Bonet E,
Oliveras-Ferraros C, Pérez-Martínez MC, Bernadó L and Menendez JA:
Mitotic kinase dynamics of the active form of AMPK (phospho-AMPK
alphaThr172) in human cancer cells. Cell Cycle. 8:788–791. 2009.
View Article : Google Scholar : PubMed/NCBI
|
